Skip to content

Patient-operated Valved Catheter Versus Indwelling Transurethral Catheter

Clinical Trial of Patient Operated Valved Catheter Compared With Standard Indwelling Transurethral Catheter for Postoperative Bladder Management

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01460303
Enrollment
49
Registered
2011-10-26
Start date
2011-01-31
Completion date
2015-12-31
Last updated
2018-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Dysfunction, Urinary Retention

Keywords

Transurethral catheterization, Urinary retention, Bladder dysfunction, Patient comfort, Pelvic Reconstructive Surgery, Postoperative bladder dysfunction, Postoperative urinary retention

Brief summary

Following surgery for female urinary incontinence and/or pelvic organ prolapse, women are sometimes temporarily unable to empty their bladders and are sent home with a transurethral indwelling catheter attached to a bag which holds urine. The goal of this study is to compare a new type of patient-operated catheter without a bag to the catheter with a bag for ease of use, comfort and quality of life for patients during the postoperative recovery period. This new catheter, the OPTION-vf, is approved by the FDA and is available on the market.

Interventions

DEVICEBladder catheter: OPTION-vf patient controlled catheter vs. indwelling transurethral catheter with leg bag

OPTION-vf patient controlled catheter (transurethral catheter with external drainage valve to provide on-demand drainage of urine stored directly from the bladder), worn maximum of 30 days post-op until bladder challenge is passed. Bladder challenge is considered passed when a patient is able to void adequately and spontaneously (without the assistance of a catheter).

DEVICETransurethral catheter with leg bag

Transurethral catheter w/leg bag urine storage, worn maximum of 30 days post-up until bladder challenge is passed. Bladder challenge is considered passed when a patient is able to void adequately and spontaneously (without the assistance of a catheter).

Sponsors

University of Massachusetts, Worcester
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients undergoing surgery for urinary incontinence and/or pelvic organ prolapse at the UMass Memorial Medical Center with one of the Urogynecology/Reconstructive Pelvic Surgery faculty.

Exclusion criteria

* inability to provide consent * \<18 years old * non-English speaking * patients using intermittent self-catheterization * patients sustaining bladder injury during surgery * prisoners * pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Total Catheter Related Pain5-10 days postoperativelyTotal Catheter Related Pain Range Scale (0 = none, to 10 = worst) on the Post Operative Questionnaire All subjects were given and appointment for an outpatient voiding trial after hospital discharge. The Post Operative questionnaire was completed by the subject one time at that appointment.

Secondary

MeasureTime frameDescription
Composite Satisfaction Score (CSS)5-10 days postoperativelyThe mean scores for the first 5 questions of the Post Operative Questionnaire were used to calculate a Composite Satisfaction Score. 1. Total Pain (0 none, 10 worst) 2. Total Catheter Related Pain Range Scale (0 none, 10 worst) 3. Ease of catheter use (0 easy, 10 difficult) 4. Feeling of frustration (0 none, 10 very much) 5. Limited social activities (0 none, 10 very much) All subjects were given and appointment for an outpatient voiding trial after hospital discharge. The Post Operative Questionnaire was completed by the subject one time at that appointment.

Participant flow

Participants by arm

ArmCount
OPTION-vf Patient Controlled Catheter
Patients who fail postop bladder challenge and are randomized to OPTION-vf arm will be instructed in the use and care of this catheter, discharged home with it in place and given an appointment between 5-10 days postop for a bladder challenge. Bladder catheter: OPTION-vf patient controlled catheter vs. indwelling transurethral catheter with leg bag: OPTION-vf patient controlled catheter (transurethral catheter with external drainage valve to provide on-demand drainage of urine stored directly from the bladder), worn maximum of 30 days post-op until bladder challenge is passed. Bladder challenge is considered passed when a patient is able to void adequately and spontaneously (without the assistance of a catheter).
25
Transurethral Catheter w/Leg Bag
Patients who fail postop bladder challenge and are randomized to indwelling catheter with leg bag arm will be instructed in the use and care of this catheter, discharged home with it in place and given an appointment between 5-10 days postop for a bladder challenge. Transurethral catheter with leg bag: Transurethral catheter w/leg bag urine storage, worn maximum of 30 days post-up until bladder challenge is passed. Bladder challenge is considered passed when a patient is able to void adequately and spontaneously (without the assistance of a catheter).
24
Total49

Baseline characteristics

CharacteristicOPTION-vf Patient Controlled CatheterTotalTransurethral Catheter w/Leg Bag
Age, Continuous61.5 years
STANDARD_DEVIATION 12.4
60.6 years
STANDARD_DEVIATION 1.27
59.7 years
STANDARD_DEVIATION 12.4
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants6 Participants3 Participants
Race (NIH/OMB)
White
22 Participants43 Participants21 Participants
Region of Enrollment
United States
25 participants49 participants24 participants
Sex: Female, Male
Female
25 Participants49 Participants24 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 240 / 25
other
Total, other adverse events
11 / 246 / 25
serious
Total, serious adverse events
0 / 240 / 25

Outcome results

Primary

Total Catheter Related Pain

Total Catheter Related Pain Range Scale (0 = none, to 10 = worst) on the Post Operative Questionnaire All subjects were given and appointment for an outpatient voiding trial after hospital discharge. The Post Operative questionnaire was completed by the subject one time at that appointment.

Time frame: 5-10 days postoperatively

ArmMeasureValue (MEDIAN)Dispersion
OPTION-vf Patient Controlled CatheterTotal Catheter Related Pain1.25 units on a scaleStandard Deviation 2.65
Transurethral Catheter w/Leg BagTotal Catheter Related Pain2.3 units on a scaleStandard Deviation 3.5
Secondary

Composite Satisfaction Score (CSS)

The mean scores for the first 5 questions of the Post Operative Questionnaire were used to calculate a Composite Satisfaction Score. 1. Total Pain (0 none, 10 worst) 2. Total Catheter Related Pain Range Scale (0 none, 10 worst) 3. Ease of catheter use (0 easy, 10 difficult) 4. Feeling of frustration (0 none, 10 very much) 5. Limited social activities (0 none, 10 very much) All subjects were given and appointment for an outpatient voiding trial after hospital discharge. The Post Operative Questionnaire was completed by the subject one time at that appointment.

Time frame: 5-10 days postoperatively

ArmMeasureValue (MEAN)Dispersion
OPTION-vf Patient Controlled CatheterComposite Satisfaction Score (CSS)2.23 units on a scaleStandard Deviation 1.83
Transurethral Catheter w/Leg BagComposite Satisfaction Score (CSS)3.62 units on a scaleStandard Deviation 1.95

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026